ICD-10-CM 2027 diagnosis code
Q85.09Other neurofibromatosis
Q85.09 is a valid, billable ICD-10-CM code for other neurofibromatosis. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About Q85.09
Q85.09 is the ICD-10-CM diagnosis code for other neurofibromatosis. It belongs to category Q85 (phakomatoses, not elsewhere classified), block Q80-Q89 (other congenital malformations) and chapter 17 (congenital malformations, deformations, chromosomal abnormalities, and genetic disorders). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.
Within Q85.0, choose Q85.09 (Other neurofibromatosis) only when documentation doesn't support a more specific option: neurofibromatosis, unspecified (Q85.00), neurofibromatosis, type 1 (Q85.01), neurofibromatosis, type 2 (Q85.02) and Schwannomatosis (Q85.03).
It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.
In MS-DRG v44.0, it is part of the grouping logic for DRG 091 (Other Disorders of Nervous System with MCC, relative weight 1.7046), DRG 092 (Other Disorders of Nervous System with CC, relative weight 1.0239) and DRG 093 (Other Disorders of Nervous System without CC/MCC, relative weight 0.7783), in MDC 01 (Diseases and Disorders of the Nervous System), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
It is exempt from present-on-admission (POA) reporting, so no POA indicator is required.
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Before ICD-10, this condition was coded in ICD-9-CM as 237.79 (other neurofibromatosis).
Notes that apply from higher levels
Instructions written at a parent level also apply to Q85.09.
Broader instructions also apply from Chapter 17: Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders.
Alphabetic index entries
1 entriesTerms in the official ICD-10-CM index that lead to Q85.09.
MS-DRG v44.0 grouping
All DRGs →Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.
MDC 01 · Diseases and Disorders of the Nervous System
ICD-9-CM equivalent
Converter →- 237.79Other neurofibromatosisexact
From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about Q85.09
Is Q85.09 billable?
- Yes. Q85.09 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can Q85.09 be used as a principal diagnosis?
- Yes. The Medicare Code Editor doesn't restrict Q85.09 as a principal diagnosis.
Is Q85.09 a CC or MCC?
- No. Q85.09 is neither a CC nor an MCC under MS-DRG v44.0.
What DRG does Q85.09 group to?
- Q85.09 is used in the MS-DRG v44.0 logic for MS-DRG 091 (Other Disorders of Nervous System with MCC), MS-DRG 092 (Other Disorders of Nervous System with CC) and MS-DRG 093 (Other Disorders of Nervous System without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.
What is the ICD-9 code for Q85.09?
- The CMS General Equivalence Mappings map Q85.09 to ICD-9-CM 237.79.